NCT05086549View on ClinicalTrials.gov

An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

June 5, 2023

Study Completion Date

June 5, 2023

Conditions
Diabetic Kidney DiseaseProteinuriaHypertension,Essential
Trial Locations (1)

Unknown

Severance hospital, Yonsei University Health System, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY